To complement the genetic finding in MC38 tumor model, we treated wildtype mice with the LSD1 chemical inhibitor, GSK287955230, daily for two weeks and found that this inhibitor acted similarly as Lsd1 genetic ablation, albeit less profoundly, in suppressing tumor growth (Fig. 1c, d). The gene discussed is KDM1A; the disease is neoplasm.